Charlotte Davison is an Investment Analyst in the Direct Life Science Investment team at British Patient Capital. British Patient Capital is a commercial subsidiary of the British Business Bank, the UK government’s economic development bank. British Patient Capital’s mission is to enable long-term investment in innovative UK companies led by ambitious entrepreneurs who want to build successful, world-class businesses. British Patient Capital’s programs target the later stage equity finance gap faced by innovative, R&D-intensive UK companies with cutting edge technologies.
Charlotte joined British Patient Capital in 2021 and has experience in technology transfer and talent acquisition. Charlotte holds a BSc. in Biochemistry and Genetics from the University of Nottingham, PhD in Computational Genetics from the University of Leicester, and an MPhil. in Bioscience Enterprise from the University of Cambridge.